MARKET

NRSN

NRSN

Neurosense Therapeutics Ltd
NASDAQ
0.7690
+0.0592
+8.34%
After Hours: 0.7697 +0.0007 +0.09% 19:10 12/31 EST
OPEN
0.7000
PREV CLOSE
0.7098
HIGH
0.7698
LOW
0.6801
VOLUME
284.84K
TURNOVER
--
52 WEEK HIGH
2.600
52 WEEK LOW
0.6801
MARKET CAP
22.84M
P/E (TTM)
-2.5875
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRSN last week (1222-1226)?
Weekly Report · 12/29/2025 09:53
NeuroSense Unveils Favourable Safety Analysis Data Of PrimeC In NST-AD-001 Study For Alzheimer's
NASDAQ · 12/23/2025 08:37
NeuroSense Reports Favorable Safety Profile for PrimeC in Phase 2 Alzheimer’s Trial
TipRanks · 12/22/2025 17:18
NeuroSense Therapeutics Is Maintained at Buy by D. Boral Capital
Dow Jones · 12/22/2025 16:11
NeuroSense Therapeutics Price Target Maintained With a $14.00/Share by D. Boral Capital
Dow Jones · 12/22/2025 16:11
D. Boral Capital Maintains Buy on NeuroSense Therapeutics, Maintains $14 Price Target
Benzinga · 12/22/2025 16:00
NeuroSense confirms favorable safety, tolerability of Prime C in Phase 2 study
TipRanks · 12/22/2025 14:25
NeuroSense Therapeutics' Analysis From Phase 2 NST-AD-001 Trial Of PrimeC Combination In Alzheimer's Demonstrates Favorable Tolerability For PrimeC
Benzinga · 12/22/2025 14:20
More
About NRSN
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Webull offers Neurosense Therapeutics Ltd stock information, including NASDAQ: NRSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRSN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRSN stock methods without spending real money on the virtual paper trading platform.